Washington, DC, January 7, 2026 (PAHO) – The Pan American Journal of Public Health, the scientific publication of the Pan American Health Organization (PAHO), recently published a special issue dedicated to strengthening primary health care to address noncommunicable diseases (NCDs) in the Americas.
To estimate the prevalence of HTLV-1 infection among the family members of positive index cases referred to a specialized center in Peru and its distribution by type of relationship and presence of diseases associated with the infection.
The growing burden of noncommunicable diseases (NCDs) cannot be addressed through clinical interventions alone. Population-level regulatory interventions—such as fiscal measures, marketing restrictions, and labeling regulations—are central to effective NCD prevention and control. This article addresses the role of regulatory policies in preventing NCDs, with a focus on progress and implementation gaps in the Americas.
To identify spatiotemporal patterns and clusters of tuberculosis (TB) in Brazil between 2001 and 2023, assess the impact of the COVID-19 pandemic on TB trends, and provide recommendations for targeted interventions.
[EXTRACT] 3 February 2026, WASHINGTON, D.C. —
To explore barriers and opportunities in implementing adolescent sexual and reproductive health interventions in four rural Indigenous communities in Alta Verapaz, Guatemala.
An exploratory descriptive qualitative study was conducted using stakeholder mapping and a reflexive thematic approach. Data were collected through 20 semistructured interviews with key stakeholders involved in adolescent sexual and reproductive health programming.
To evaluate the effect of using asynchronous geriatric consultations to reduce polypharmacy and unscheduled consultations in older persons in Chile.
Health systems in the Amazon face deep structural challenges that limit access to timely and quality care. This study provides a cross-country comparative analysis of health care infrastructure and hospital utilization in the Amazon, with a particular focus on urban settlements.
[EXTRACT] Dear Editor,
Despite significant advancements in therapy and improved survival rates, gaps persist in achieving equal outcomes across the more than 100 lymphoma subtypes identified globally. In the United States (US) alone, the 5-year survival for non-Hodgkin lymphoma (NHL) rose from 62% in 2000 to 75% in 2017, and for Hodgkin lymphoma, from 82% to 90%, respectively (1). However, survival outcomes for virus-associated lymphomas have remained relatively stable in the US. [...]
